Literature DB >> 22200024

Malignant ascites after subduroperitoneal shunt in a patient with leptomeningeal metastasis.

Min Ho Lee1, Jung-Il Lee.   

Abstract

Leptomeningeal metastasis is a devastating complication of advanced stage cancer. It is frequently accompanied by hydrocephalus and intracranial hypertension that must be treated by ventriculoperitoneal shunts. However, there are actual risks of peritoneal seeding or accumulation of malignant ascites after the cerebrospinal fluid diversion procedure, though it has not been reported. Here, we present the case of a patient with non-small cell lung cancer with leptomeningeal metastasis in whom malignant ascites developed after a subduroperitoneal shunt.

Entities:  

Keywords:  Leptomeningeal metastasis; Malignant ascites; Ventriculoperitoneal shunt

Year:  2011        PMID: 22200024      PMCID: PMC3243845          DOI: 10.3340/jkns.2011.50.4.385

Source DB:  PubMed          Journal:  J Korean Neurosurg Soc        ISSN: 1225-8245


  11 in total

1.  Abdominal metastases of medulloblastoma related to a ventriculoperitoneal shunt.

Authors:  Ferdinando Loiacono; Aldo Morra; Silvia Venturini; Luca Balestreri
Journal:  AJR Am J Roentgenol       Date:  2006-06       Impact factor: 3.959

2.  A novel method for administering intrathecal chemotherapy in patients with leptomeningeal metastases and shunted hydrocephalus: case report.

Authors:  Gabriel Zada; Thomas C Chen
Journal:  Neurosurgery       Date:  2010-09       Impact factor: 4.654

Review 3.  Extraneural metastases of paediatric brain tumours.

Authors:  Christian H Rickert
Journal:  Acta Neuropathol       Date:  2003-01-21       Impact factor: 17.088

4.  A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.

Authors:  M J Glantz; K A Jaeckle; M C Chamberlain; S Phuphanich; L Recht; L J Swinnen; B Maria; S LaFollette; G B Schumann; B F Cole; S B Howell
Journal:  Clin Cancer Res       Date:  1999-11       Impact factor: 12.531

5.  Ventriculoperitoneal shunt complications in hydrocephalus patients with intracranial tumors: an analysis of relevant risk factors.

Authors:  G Kesava Reddy; Papireddy Bollam; Gloria Caldito; Brian Willis; Bharat Guthikonda; Anil Nanda
Journal:  J Neurooncol       Date:  2010-09-15       Impact factor: 4.130

6.  Ommaya reservoirs for the treatment of leptomeningeal metastases.

Authors:  D I Sandberg; M H Bilsky; M M Souweidane; J Bzdil; P H Gutin
Journal:  Neurosurgery       Date:  2000-07       Impact factor: 4.654

Review 7.  Leptomeningeal metastases: a review of evaluation and treatment.

Authors:  M C Chamberlain
Journal:  J Neurooncol       Date:  1998-05       Impact factor: 4.130

8.  Leptomeningeal metastasis: survival and prognostic factors in 155 patients.

Authors:  Ulrich Herrlinger; Heike Förschler; Wilhelm Küker; Richard Meyermann; Michael Bamberg; Johannes Dichgans; Michael Weller
Journal:  J Neurol Sci       Date:  2004-08-30       Impact factor: 3.181

9.  Peritoneal dissemination from central neurocytoma: case report.

Authors:  Maurício Coelho Neto; Ricardo Ramina; Murilo Sousa de Meneses; Walter Oleschko Arruda; Jerônimo Buzetti Milano
Journal:  Arq Neuropsiquiatr       Date:  2004-01-06       Impact factor: 1.420

10.  Leptomeningeal dissemination of ovarian carcinoma through a ventriculoperitoneal shunt.

Authors:  Yesim Eralp; Pinar Saip; Zeki Aydin; Sinan Berkman; Erkan Topuz
Journal:  Gynecol Oncol       Date:  2007-10-24       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.